Galmed Pharmaceuticals (GLMD) EBT Margin (2016 - 2018)
Galmed Pharmaceuticals (GLMD) recorded quarterly EBT Margin of 58.93% in Q3 2018, down 94.07% quarter-over-quarter from 994.44% in Q2 2018, and down 96707.0% on a YoY basis from N/an in Q3 2017.
Galmed Pharmaceuticals (GLMD) EBT Margin (2016 - 2018) Analysis & Trends
Galmed Pharmaceuticals' EBT Margin history runs 3 years deep, the most recent figure standing at 58.93% for Q3 2018.
- In Q3 2018, EBT Margin fell 96707.0% year-over-year to 58.93%; the TTM figure through Dec 2018 stood at 485.13% (down 66722.0% YoY), while the FY2018 annual figure was 479.93%, down 65362.0% from the prior year.
- EBT Margin was 58.93% for Q3 2018 at Galmed Pharmaceuticals, down from 994.44% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1931.09% in Q3 2016 to a low of 58.93% in Q3 2018.
- Historically, EBT Margin has averaged 1147.71% across 3 years, with a median of 1026.01% in 2017.
- Biggest YoY gain for EBT Margin was 259 bps in 2018; the steepest drop was 96707 bps in 2018.
- A 3-year view of EBT Margin shows it stood at 1761.31% in 2016, then dropped by 24 bps to 1329.93% in 2017, then sank by 96 bps to 58.93% in 2018.
- The last three EBT Margin figures came in at 58.93% (Q3 2018), 994.44% (Q2 2018), and 974.63% (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 58.93% |
| Jun 30, 2018 | 994.44% |
| Mar 31, 2018 | 974.63% |
| Dec 31, 2017 | 1,329.93% |
| Sep 30, 2017 | 1,026.01% |
| Jun 30, 2017 | 997.04% |
| Mar 31, 2017 | 1,255.97% |
| Dec 31, 2016 | 1,761.31% |
| Sep 30, 2016 | 1,931.09% |